Literature DB >> 6179890

Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigen.

J J Ballet, A Morin, C Schmitt, M Agrapart.   

Abstract

Isoprinosine, a synthetic purine derivative, did not significantly interfere with the thymidine uptake of triggered normal lymphocytes, nor exhibit a detectable mitogenic activity. Isoprinosine was able to significantly enhance specific proliferative responses of human lymphocytes from sensitized donors to soluble antigens. Isoprinosine did not alter the early interaction of human mononuclear cells with 125I-labelled antigen, nor the expression of their membrane receptors for immunoglobulin Fc fragments. The agent could not replace the accessory rôle of adherent cells in proliferative responses to antigens. The enhancing effect of isoprinosine on antigen specific responses of T-cells was observed upon adding the compound on any one of the seven days of culture. Isoprinosine partially restored the inhibited proliferation of lymphocytes cultured in the presence of deoxyadenosine and deoxycoformycin. Data suggest that metabolic changes involving purines may account for the effect of isoprinosine on the expression of T-cell responses.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179890     DOI: 10.1016/0192-0561(82)90043-1

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  7 in total

1.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1985       Impact factor: 3.553

2.  Immunostimulation. Clinical and experimental perspectives.

Authors:  J Drews
Journal:  Klin Wochenschr       Date:  1984-03-15

3.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

Review 4.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

5.  Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression.

Authors:  Michael T McCarthy; Da Lin; Tomoyoshi Soga; Julie Adam; Christopher A O'Callaghan
Journal:  Eur J Immunol       Date:  2019-09-12       Impact factor: 5.532

6.  Influence of Inosine Pranobex on Cell Viability in Normal Fibroblasts and Liver Cancer Cells.

Authors:  Sylwia Tobólska; Sylwia Terpiłowska; Jerzy Jaroszewski; Andrzej Krzysztof Siwicki
Journal:  J Vet Res       Date:  2018-10-24       Impact factor: 1.744

7.  Genotoxicity and Mutagenicity of Inosine Pranobex.

Authors:  Sylwia Tobólska; Sylwia Terpiłowska; Jerzy Jaroszewski; Andrzej Krzysztof Siwicki
Journal:  J Vet Res       Date:  2018-10-24       Impact factor: 1.744

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.